Anna Ryan Hemnes MD
Critical Care Medicine, Pulmonary Vascular Medicine
System Physician-in-Chief, Hugh Jackson Morgan Chair of Medicine, Professor of Medicine, Vanderbilt Health
Join to view full profile
1161 21st Ave S# T1218Nashville, TN 37232
Phone+1 615-343-0135
Fax+1 615-321-6393
Dr. Hemnes is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Anna Hemnes is a pulmonologist based in Nashville, TN, with subspecialties in Critical Care Medicine and Pulmonary Vascular Medicine. She completed her medical education and training at Johns Hopkins University, finishing a fellowship in Pulmonary Disease and Critical Care Medicine in 2006. Dr. Hemnes has experience in pulmonary arterial hypertension, severity of illness index, and insulin resistance. Her recent publications include studies on pulmonary arterial hypertension and related conditions. She has conducted clinical trials addressing insulin resistance in pulmonary arterial hypertension.
Education & Training
Johns Hopkins UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 2002 - 2006- Johns Hopkins UniversityResidency, Internal Medicine, 1999 - 2002
- Johns Hopkins University School of MedicineClass of 1999
Certifications & Licensure
TN State Medical License 2006 - 2027
AL State Medical License 2020 - 2020
MD State Medical License 2003 - 2006
American Board of Internal Medicine Critical Care Medicine- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification BI-Clinical, CitiusTech, Inc., 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification StarPanel, Vanderbilt University, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification StarPanel, Vanderbilt University, 2012, 2014-2017
Clinical Trials
- Interventions Against Insulin Resistance in Pulmonary Arterial Hypertension Start of enrollment: 2018 Aug 23
Publications & Presentations
PubMed
- 3 citationsCharacteristics of Patients with Pulmonary Arterial Hypertension Receiving Selexipag in the SPHERE Registry by Race and Ethnicity.Harrison W Farber, Murali M Chakinala, Anna R Hemnes, Kelly M Chin, Kristin B Highland
Journal of Racial and Ethnic Health Disparities. 2026-10-01 - Pulmonary Artery Dilation on Chest CT Across the Spectrum of Chronic Lung Disease.Tyler J Couch, Gerald J Beck, Erika Berman Rosenzweig, J Jeffrey Carr, Joao A de Andrade
Chest. 2026-09-24 - Pulmonary Primary Oxysterol and Bile Acid Synthesis as a Predictor of Outcomes in Pulmonary Arterial Hypertension.Mona Alotaibi, Lloyd D Harvey, William C Nichols, Anna Hemnes, Wei Sun
American Journal of Respiratory and Critical Care Medicine. 2026-08-26
Press Mentions
Department of Medicine Names Evan Brittain, Kathryn Dahir to Research Leadership PositionsJune 16th, 2026- Lung Researchers at VUMC Win Prestigious FellowshipsMay 21st, 2025
- Lung Researchers at VUMC Win Prestigious FellowshipsMay 20th, 2025
Grant Support
- Genomic and Circulating Predictors of PAH responseVANDERBILT UNIVERSITY MEDICAL CENTER2019–2028
- Carnitine supplementation in pulmonary arterial hypertensionVANDERBILT UNIVERSITY MEDICAL CENTER2026–2027
- Network Medicine and Systems Pharmacology to Advance Precision Medicine in Combined Pulmonary HypertensionVANDERBILT UNIVERSITY MEDICAL CENTER2022–2027
- Mentorship in Pulmonary Vascular DiseaseVANDERBILT UNIVERSITY MEDICAL CENTER2022–2026
- Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible IndividualsVANDERBILT UNIVERSITY MEDICAL CENTER2022–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: